Jefferies just named five U.S. dividend stocks to its exclusive Global Best Ideas list, and with the S&P 500 stretched to historically expensive valuations, the case for these high-conviction picks ha
Morgan Stanley analyst Tejas Savant maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $620 to $650.
WALTHAM, Mass., July 27, 2026--Thermo Fisher Scientific, the world leader in serving science, will showcase its latest diagnostic innovations, recent regulatory milestones and expanded capabilities at
MNST, CRS and USIO highlight Zacks strategies that outperformed amid a volatile market.
With 27% of S&P 500 companies reporting, 86% have beaten earnings estimates and 80% have exceeded revenue expectations, according to FactSet. Read more here.
Thermo Fisher Scientific's (TMO) broad-based improvement in Q2 is not enough to "meaningfully" chang
Dan Loeb reduced his Danaher stake and exited Thermo Fisher in Q1 2026 as the billionaire investor trimmed life sciences exposure.
Life sciences company Thermo Fisher (NYSE:TMO) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 10.5% year on year to $11.99 billion. Its non-GAAP profit of $6.03 pe
View interactive chart, options flow, and AI analysis for TMO on Zorveq Finance.
Open TMO Chart & Analysis →